Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

Invasive strains of non-typhoidal salmonellae have emerged as a prominent cause of
bloodstream infection in African adults and children, with an associated case fatality of 20 …

Background For patients with bacteraemia caused by methicillin-sensitive Staphylococcus
aureus anti-staphylococcal penicillins (ASPs) or cefazolin are agents of choice. While ASPs …

Clinical management of Staphylococcus aureus infections presents a challenge due to the
high incidence, considerable virulence, and emergence of drug resistance mechanisms …

We evaluated the incidence, outcomes, and causative agents of bloodstream infections
(BSI) in Finland during 2004–2018 by using data from the national registries. We identified a …

Importance Staphylococcus aureusbacteremia (SAB) in children causes significant morbidity
and mortality, but the epidemiology in children is not well characterized. Objective To …

Importance Staphylococcus aureusbacteremia is common and frequently associated with
poor outcomes. Evidence indicates that specific care processes are associated with …

Treatment of Staphylococcus aureus bloodstream infections in selected low-risk patients
with an early oral switch to linezolid between days 3 and 9 of treatment until completion …

Staphylococcus aureus bacteremia (SAB) is a major cause of illness and death worldwide.
We analyzed temporal trends of SAB incidence and death in Denmark during 2008–2015 …

Importance There is a recognized unmet need for clinical trials to provide evidence-informed
care for infants, children and adolescents. This Special Communication outlines the capacity …